The global rheumatology therapeutics market was valued at US$48.8 Bn in 2023 and is projected to expand at a CAGR of 2.6% from 2024 to 2034, reaching approximately US$65.1 Bn by the end of 2034. Increasing prevalence of rheumatoid arthritis (RA), an aging population, growing disease awareness, and continued research into disease-modifying therapies are supporting long-term market development. 👉...